Inhibition of TNF-α produced by Kupffer cells protects against the nonspecific liver toxicity of immunotoxin anti-TAC(Fv)-PE38, LMB-2

Journal of Immunology

Volumn 165, Issue 12, 2000, Pages 7150-7156

  Onda, M ^a   Willingham, M ^a   Wang, Q C ^a   Kreitman, R J ^a   Tsutsumi, Y ^a   Nagata, S ^a   Pastan, I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOTOXIN; IMMUNOTOXIN LMB2; INDOMETACIN; PSEUDOMONAS EXOTOXIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; KUPFFER CELL; LIVER CANCER; LIVER CELL; LIVER PROTECTION; LIVER TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034671634     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.12.7150     Document Type: Article

References (26)

1. Targeted therapy of cancer with recombinant immunotoxin
2. Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mine of an interleukin-2 receptor-expressing human carcinoma
3. Responses in refractory hairy cell leukemia to a recombinant immunotoxin
4. Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies
5. Reduction of the nonspecific animal toxicity of anti-Tac(Fv)-PE38 by mutations in the framework regions of the Fv which lower the isoelectric point
6. Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in Escherichia coli
7. T-cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin-B critical role of tumor-necrosis-factor
8. Diphtheria toxin-mediated and Pseudomonas A toxin-mediated apoptosis-ADP ribosylation of elongation factor-II is required for DNA fragmentation and cell-lysis and synergy with tumor-necrosis-factor-α
9. Acute hepatoxicity of Pseudomonas aeruginosa exotoxin A in mice depends on T cells and TNF
10. Active-site of Pseudomonas aeruginosa exotoxin-A-glutamic acid-553 is photolabeled by NAD and shows functional homology with glutamic acid-148 of diphtheria-toxin
11. Two tumor necrosis factor-binding proteins purified from human urine evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors
12. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist
13. Glucose-transport in murine macrophages in vitro characterization of the monosaccharide transport-system of the thioglycollate-elicited mouse peritoneal macrophage
14. Complete regression of human B-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4(dsFv)-PE38 at doses tolerated by cynomolgus monkeys
15. Nonparametric estimation from incomplete observations
16. Regulatin of the messenger-RNA expression for tumor-necrosis-factor-α in rat-liver macrophages
17. Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T-cell-dependent liver-injury in mice
18. Effect of prostaglandin-E1 on syntheses of tumor-necrosis-factor (TNF) and interleukin-1 (IL-1) by hepatic adherent cells in mice with massive liver necrosis
19. Phase 1 trial of recombinant interleukin-2 followed by recombinant tumor-necrosis-factor in patients with metastasic cancer
20. Increased cytotoxic activity of Pseudomonas exotoxin and 2 chimeric toxins ending in KDEL
21. The influence of modulating substances on tumor-necrosis-factor and interleukin-6 levels after injection of murine tumor-necrosis-factor or lipopolysaccharide in mice
22. Prostaglandin-E2 inhibits the release of tumor-necrosis-factor-α, rather than interleukin-1-β, from human macrophages
23. Characterization of vascular leak syndrome reduced by the toxin component of Pseudomonas exotoxin-based immunotoxins and its potential inhibition with nonsteroidal anti-inflammatory drugs
24. BR96 sFv-PE40 immunotoxin nonclinical safety assessment
25. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
26. Infliximab for the treatment of fistulas in patients with Crohn's disease